A

Accelerate Diagnostics
D

AXDX

1.19000
USD
0.08
(7.21%)
مغلق
حجم التداول
200
الربح لكل سهم
0
العائد الربحي
-
P/E
-0
حجم السوق
29,802,148
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    COO
    COO
    -0.180
    (-0.20%)
    88.490 USD
    DHR
    DHR
    2.150
    (1.03%)
    210.170 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    H
    HOLX
    0.180
    (0.28%)
    64.510 USD
    ILMN
    ILMN
    -3.080
    (-3.17%)
    94.180 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    P
    PODD
    -5.82
    (-2.02%)
    282.56 USD
    RMD
    RMD
    -1.320
    (-0.57%)
    231.520 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    المزيد
الأخبار
المقالات

العنوان: Accelerate Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.